|
HCG11 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.184400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.491400E-01 |
| Normal-vs-Stage2 |
5.855600E-01 |
| Normal-vs-Stage3 |
1.988210E-02 |
| Normal-vs-Stage4 |
4.222700E-03 |
| Stage1-vs-Stage2 |
4.236200E-01 |
| Stage1-vs-Stage3 |
3.579400E-03 |
| Stage1-vs-Stage4 |
7.242800E-04 |
| Stage2-vs-Stage3 |
3.821400E-01 |
| Stage2-vs-Stage4 |
1.756410E-01 |
| Stage3-vs-Stage4 |
4.453600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.154600E-01 |
| Normal-vs-AfricanAmerican |
1.477950E-01 |
| Normal-vs-Asian |
6.606200E-01 |
| Caucasian-vs-AfricanAmerican |
3.468200E-01 |
| Caucasian-vs-Asian |
3.749200E-01 |
| AfricanAmerican-vs-Asian |
2.566600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.011400E-01 |
| Normal-vs-Female |
4.171900E-04 |
| Male-vs-Female |
2.64640000002814E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.141000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.357600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.843600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.504250E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.020400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.741200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.800100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.738580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.123410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.770000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.794200E-01 |
| Normal-vs-Grade 2 |
5.844000E-01 |
| Normal-vs-Grade 3 |
1.930760E-01 |
| Normal-vs-Grade 4 |
2.38739999999238E-05 |
| Grade 1-vs-Grade 2 |
8.563600E-01 |
| Grade 1-vs-Grade 3 |
3.808400E-01 |
| Grade 1-vs-Grade 4 |
1.041740E-02 |
| Grade 2-vs-Grade 3 |
5.954400E-02 |
| Grade 2-vs-Grade 4 |
1.18599999998636E-06 |
| Grade 3-vs-Grade 4 |
1.299450E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.494100E-02 |
| Normal-vs-ccB subtype |
2.177200E-04 |
| ccA subtype-vs-ccB subtype |
4.13449996461424E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.332100E-02 |
| Normal-vs-N1 |
1.980620E-01 |
| N0-vs-N1 |
3.620400E-01 |
|
|
